The tumor suppressor ING1: Structure and function

Experimental Cell Research

Volumn 268, Issue 1, 2001, Pages 1-6

  Cheung Jr , K John ^a   Li, Gang ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

ING1; P53; Tumor suppressor

Indexed keywords

CELL PROTEIN; GAG PROTEIN; GENE PRODUCT; PROTEIN ING1; PROTEIN P27; PROTEIN P32; PROTEIN P47; PROTEIN P53; SUPPRESSOR FACTOR; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANCHORAGE INDEPENDENT GROWTH; APOPTOSIS; CELL CYCLE; CHEMOSENSITIVITY; GENE ISOLATION; GROWTH DISORDER; HUMAN; MITOSIS INHIBITION; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN STRUCTURE; SENESCENCE; SHORT SURVEY; STRUCTURE ACTIVITY RELATION; TUMOR SUPPRESSOR GENE;

EID: 0035425570     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2001.5258     Document Type: Article

References (47)

1. ING1 promotes neoplastic transformation
2. Genetic suppressor elements: New tools for molecular oncology - Thirteenth Cornelius P. Rhoads Memorial Award Lecture
3. Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas
4. p24/ING1-ALT1 and p47/ING1-ALT2, distinct alternative transcripts of p33/ING1
5. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: Characterization of tissue-specific ING1 transcripts and a homologue gene
6. Correction
7. Cellular localization and chromosome mapping of a novel candidate tumor suppressor gene (ING1)
8. Localization of the candidate tumor suppressor gene ING1 to human chromosome 13q34
9. ING1 cooperates with p53 in cell growth control
10. p53 mutations in human cancers
11. Clinical implications of p53 mutations
12. Tumor suppressor p53: Regulation and function
13. The complexity of p53 modulation: Emerging patterns from divergent signals
14. Twenty years of p53 research: Structural and functional aspects of the p53 protein
15. Decreased DNA repair but normal apoptosis in UV-exposed keratinocytes of p53 transgenic mice
16. Differentiation-dependent p53 regulation of nucleotide excision repair in keratinocytes
17. p53-regulated apoptosis is differentiation-dependent in UVB irradiated mouse keratinocytes
18. Waf1: A potential mediator of p53 tumor suppression
19. The p21 cdk-interacting protein cip1, is a potent inhibitor of G1 cyclin-dependent kinases
20. ING1 candidate tumor suppressor
21. A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis
22. Caspases and mitochondria in c-Myc-induced apoptosis: Identification of ATM as a new target of caspases
23. c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release
24. Genetic dissection of c-myc apoptotic pathways
25. An amino-terminal c-myc domain required for neoplastic transformation activates transcription
26. Adenovirus-mediated transfer of p33ING1 with p53 drastically augments apoptosis in gliomas
27. Differential association of products of alternative transcripts of the candidate tumor suppressor ING1 with the mSin3/HDAC1 transcriptional corepressor complex
28. Histone acetylation and transcriptional regulatory mechanisms
29. Sin meets NuRD and other tails of repression
30. Cloning of a novel gene (ING1L) homologous to ING1, a candidate tumor suppressor
31. Structure and regulation of the mouse ING1 gene
32. Expression of the novel tumour suppressor p33(ING1) is independent of p53
33. Three yeast proteins related to the human candidate tumor suppressor p33(ING1) are associated with histone acetyltransferase activities
34. The many HATs of transcription coactivators
35. Gene activation by histone and factor acetyltransferases
36. Decreased expression of p33ING1 mRNA in lymphoid malignancies
37. Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer
38. The candidate tumour suppressor gene, ING1, is retained in colorectal carcinomas
39. Suppression of ING1 expression in sporadic breast cancer
40. Diminished expression of ING1 mRNA and the correlation with p53 expression in breast cancers
41. Molecular analysis of the candidate tumor suppressor gene ING1 in human head and neck tumors with 13q deletions
42. Hypermethylation of E-cadherin in leukemia
43. Viruses in human cancers
44. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
45. Amplification of a gene encoding a p53-associated protein in human sarcomas
46. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
47. Mdm2 expression is induced by wild type p53 activity